Clinical Trial Update: Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial investigating switching from ticagrelor to prasugrel in patients with acute coronary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• PRASUGREL (prasugrel)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Acute Coronary Syndrome | Phase 4 | Status: UNKNOWN